- Home
- JFR vs YDES Comparison
JFR vs YDES Comparison
Compare JFR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFR
- YDES
- Stock Information
- Founded
- JFR 2004
- YDES 2013
- Country
- JFR United States
- YDES Taiwan
- Employees
- JFR N/A
- YDES N/A
- Industry
- JFR Trusts Except Educational Religious and Charitable
- YDES
- Sector
- JFR Finance
- YDES
- Exchange
- JFR Nasdaq
- YDES Nasdaq
- Market Cap
- JFR 1.3B
- YDES 1.1B
- IPO Year
- JFR N/A
- YDES N/A
- Fundamental
- Price
- JFR $7.90
- YDES $11.43
- Analyst Decision
- JFR
- YDES
- Analyst Count
- JFR 0
- YDES 0
- Target Price
- JFR N/A
- YDES N/A
- AVG Volume (30 Days)
- JFR 621.7K
- YDES 61.1K
- Earning Date
- JFR 01-01-0001
- YDES 09-30-2025
- Dividend Yield
- JFR 11.31%
- YDES N/A
- EPS Growth
- JFR N/A
- YDES N/A
- EPS
- JFR N/A
- YDES N/A
- Revenue
- JFR N/A
- YDES $510,360.00
- Revenue This Year
- JFR N/A
- YDES N/A
- Revenue Next Year
- JFR N/A
- YDES N/A
- P/E Ratio
- JFR N/A
- YDES N/A
- Revenue Growth
- JFR N/A
- YDES 45.76
- 52 Week Low
- JFR $7.61
- YDES $5.30
- 52 Week High
- JFR $8.82
- YDES $25.00
- Technical
- Relative Strength Index (RSI)
- JFR 40.23
- YDES N/A
- Support Level
- JFR $7.84
- YDES N/A
- Resistance Level
- JFR $8.15
- YDES N/A
- Average True Range (ATR)
- JFR 0.06
- YDES 0.00
- MACD
- JFR 0.02
- YDES 0.00
- Stochastic Oscillator
- JFR 57.30
- YDES 0.00
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.